{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/46951"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/46951","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Lead compound discovery for myotonic dystrophy","abstract":"Myotonic dystrophy is a debilitating genetic disorder which currently does not have a therapeutic treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy is to target such mutant mRNA with small molecules to prevent the sequestration of splicing factors which will prevent the multiple missplicing events in the cell and rescue the symptoms of the disorder. In the following thesis I describe my work in identifying small molecule inhibitors of the RNA-protein complex through the optimization of gel shift assays for characterization of rationally-designed compounds and the development of a fluorescence anisotropy assay for a high-throughput screening of the NCI Diversity Set III compound library. From such studies I was able to identify several lead compounds that are successful at inhibiting the pathological nuclear aggregation.","abstract_html":"Myotonic dystrophy is a debilitating genetic disorder which currently does not have a therapeutic treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy is to target such mutant mRNA with small molecules to prevent the sequestration of splicing factors which will prevent the multiple missplicing events in the cell and rescue the symptoms of the disorder. In the following thesis I describe my work in identifying small molecule inhibitors of the RNA-protein complex through the optimization of gel shift assays for characterization of rationally-designed compounds and the development of a fluorescence anisotropy assay for a high-throughput screening of the NCI Diversity Set III compound library. From such studies I was able to identify several lead compounds that are successful at inhibiting the pathological nuclear aggregation.","abstract_has_math":false,"creators":["Ho, Yen-Jun"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"M.S.","degree_level":"Thesis","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Zimmerman, Steven C."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013-05","date_published":"2013-05","updated_at":"2026-07-22T22:25:38Z","subjects":["myotonic dystrophy","small molecules","fluorescence anisotropy","high-throughput screen","RNA targeting","MBNL1","CUG repeats"],"languages":["en"],"rights":["Copyright 2013 Yen-Jun Ho"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/46951","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Zimmerman, Steven C."]},{"key":"dc:creator","label":"Author","values":["Ho, Yen-Jun"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013-05","2013-06-03T15:31:44Z","2014-01-16T18:39:04Z","2013-06-03"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["myotonic dystrophy","small molecules","fluorescence anisotropy","high-throughput screen","RNA targeting","MBNL1","CUG repeats"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2013 Yen-Jun Ho"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/46951"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Myotonic dystrophy is a debilitating genetic disorder which currently does not have a therapeutic treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy is to target such mutant mRNA with small molecules to prevent the sequestration of splicing factors which will prevent the multiple missplicing events in the cell and rescue the symptoms of the disorder. In the following thesis I describe my work in identifying small molecule inhibitors of the RNA-protein complex through the optimization of gel shift assays for characterization of rationally-designed compounds and the development of a fluorescence anisotropy assay for a high-throughput screening of the NCI Diversity Set III compound library. From such studies I was able to identify several lead compounds that are successful at inhibiting the pathological nuclear aggregation.","Item withdrawn by Mark Zulauf (zulauf@illinois.edu) on 2013-01-16T19:19:26Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 2 YJH Thesis-Final.docx: 1654579 bytes, checksum: 4b764cd1199a4ce6223ded9e4e6f12b3 (MD5) Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5)","Made available in DSpace on 2013-06-03T15:31:44Z (GMT). No. of bitstreams: 3 Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) Ho_Yenjun.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5)","Item reinstated by Joseph Torchedlo (torched2@illinois.edu) on 2013-06-03T15:31:44Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 3 Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) Ho_Yenjun.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5)","Item withdrawn by Mark Zulauf (zulauf@illinois.edu) on 2013-06-06T16:58:31Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 5 SUBMISSION_LOG.csv: 15804 bytes, checksum: e819342a14f9c0e8af4140f4209102f8 (MD5) MODS.xml: 3980 bytes, checksum: 0d3447a16b370dd9ef0c9ae5fd838274 (MD5) Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) HO-THESIS.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5)","Made available in DSpace on 2014-01-16T18:39:04Z (GMT). No. of bitstreams: 5 Yen-Jun_Ho.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5) SUBMISSION_LOG.csv: 15804 bytes, checksum: e819342a14f9c0e8af4140f4209102f8 (MD5) MODS.xml: 3980 bytes, checksum: 0d3447a16b370dd9ef0c9ae5fd838274 (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) license.txt: 4056 bytes, checksum: 62474b79213e899eab054d5f8d9b9ab0 (MD5) Previous issue date: 2013-06-03"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Lead compound discovery for myotonic dystrophy"]}]}],"canonical_facts":{"dc:contributor":["Zimmerman, Steven C."],"dc:creator":["Ho, Yen-Jun"],"dc:date":["2013-05","2013-06-03T15:31:44Z","2014-01-16T18:39:04Z","2013-06-03"],"dc:description":["Myotonic dystrophy is a debilitating genetic disorder which currently does not have a therapeutic treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy is to target such mutant mRNA with small molecules to prevent the sequestration of splicing factors which will prevent the multiple missplicing events in the cell and rescue the symptoms of the disorder. In the following thesis I describe my work in identifying small molecule inhibitors of the RNA-protein complex through the optimization of gel shift assays for characterization of rationally-designed compounds and the development of a fluorescence anisotropy assay for a high-throughput screening of the NCI Diversity Set III compound library. From such studies I was able to identify several lead compounds that are successful at inhibiting the pathological nuclear aggregation.","Item withdrawn by Mark Zulauf (zulauf@illinois.edu) on 2013-01-16T19:19:26Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 2 YJH Thesis-Final.docx: 1654579 bytes, checksum: 4b764cd1199a4ce6223ded9e4e6f12b3 (MD5) Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5)","Made available in DSpace on 2013-06-03T15:31:44Z (GMT). No. of bitstreams: 3 Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) Ho_Yenjun.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5)","Item reinstated by Joseph Torchedlo (torched2@illinois.edu) on 2013-06-03T15:31:44Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 3 Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) Ho_Yenjun.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5)","Item withdrawn by Mark Zulauf (zulauf@illinois.edu) on 2013-06-06T16:58:31Z Item was in collections: University of Illinois Theses & Dissertations (ID: 1) No. of bitstreams: 5 SUBMISSION_LOG.csv: 15804 bytes, checksum: e819342a14f9c0e8af4140f4209102f8 (MD5) MODS.xml: 3980 bytes, checksum: 0d3447a16b370dd9ef0c9ae5fd838274 (MD5) Ho_Yenjun.pdf: 2020072 bytes, checksum: d6da67cf9cb552f7fbd0309790d70c8e (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) HO-THESIS.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5)","Made available in DSpace on 2014-01-16T18:39:04Z (GMT). No. of bitstreams: 5 Yen-Jun_Ho.pdf: 2022115 bytes, checksum: cabd7142285b97a2a5e5d0a7fddf6e72 (MD5) SUBMISSION_LOG.csv: 15804 bytes, checksum: e819342a14f9c0e8af4140f4209102f8 (MD5) MODS.xml: 3980 bytes, checksum: 0d3447a16b370dd9ef0c9ae5fd838274 (MD5) YJH Thesis-Final.docx: 1656923 bytes, checksum: 0ccbf29403e2ce9054af130d8aae7037 (MD5) license.txt: 4056 bytes, checksum: 62474b79213e899eab054d5f8d9b9ab0 (MD5) Previous issue date: 2013-06-03"],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/46951"],"dc:language":["en"],"dc:rights":["Copyright 2013 Yen-Jun Ho"],"dc:subject":["myotonic dystrophy","small molecules","fluorescence anisotropy","high-throughput screen","RNA targeting","MBNL1","CUG repeats"],"dc:title":["Lead compound discovery for myotonic dystrophy"],"dc:type":["text"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:25:38Z"}